Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors
- 28 February 1997
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 67 (2) , 273-277
- https://doi.org/10.1016/s0015-0282(97)81910-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Circulating Nitrite/Nitrate Levels Increase with Follicular Development: Indirect Evidence for Estradiol-Mediated NO ReleaseBiochemical and Biophysical Research Communications, 1994
- Venoconstriction to Endothelin-1 in Humans Is Attenuated by Local Generation of Prostacyclin But Not Nitric OxideJournal of Cardiovascular Pharmacology, 1993
- Plasma endothelin levels are increased during septic shockCritical Care Medicine, 1992
- Endothelin is a potent mitogen for rat vascular smooth muscle cellsAtherosclerosis, 1989
- Inhibition of platelet-derived mitogen release by nitric oxide (EDRF)Inflammation Research, 1989
- Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Endothelin stimulates the release of prostacyclin from rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1989
- Elimination of Intravenously Injected Endothelin-1 from the Circulation of the RatJournal of Cardiovascular Pharmacology, 1989
- Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cellsFEBS Letters, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988